Anti-Infliximab (Remicade®) (Human) ELISA Kit

Product Overview

A sandwich ELISA kit for the quantitative measurement of Anti-Infliximab (Remicade®) in Human serum and plasma.

Infliximab (Remicade®) is a therapeutic chimeric monoclonal antibody against tumor necrosis factor (TNF) and is used to treat rheumatic arthritis, intestinal disorders, dermatological diseases and cancer. Infliximab drug inhibits the action of TNF and reduces the inflammation and subsequently improves the patient’s health. Drug level quantification can be important to adapt patient prescription or to switch to an alternative TNF inhibitor drug. Infliximab is used for the treatment of psoriasis, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis. However, some patients develop unwanted immunogenicity, which leads to production of anti-drug-antibodies (ADAs) inactivating the therapeutic effects of the treatment and, in rare cases, inducing adverse effects. 96Trace’s BioSimTM anti-Infliximab ELISA kit is designed to quantify/measure the antibody against Infliximab with high specificity and sensitivity in biological matrices.

Assay Information

Performance Data

Applications

This ELISA kit is used for quantitative measurement of Anti-Infliximab (Remicade®) in Human serum and plasma.

Features & Benefits

• Designed for quantitative measurement of Anti-Infliximab (Remicade®).
• Assay format: Sandwich ELISA.
• Sample type: Human serum and plasma.
• Detection method: Absorbance (450 nm).
• Detection Range: 62 - 500 ng/ml
• Sensitivity: 15 ng/ml
• Kit size: 96 Well.

Storage & Shipping

Product Details